Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice.

ABSTRACT:

SUBMITTER: Delforge M 

PROVIDER: S-EPMC9722575 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature